RxDoctor Payments DataLook up a doctor →

Stephanie Johnston, NP

Family · Phoenix, AZNPI 1407229628

Payments from drug & device makers

$24,795in general payments, 2019–2025

Across 296 payments — averaging $83.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sobi, Inc$9K
  • Lilly USA, LLC$3K
  • Pharmacyclics LLC, An Abbvie Company$2K
  • Seagen Inc.$2K
  • Pfizer$782
  • Incyte Corporation$781
  • plus $8K from 53 others

What the payments were for

  • Consulting fees$5,98424%
  • Speaking & faculty fees$5,03020%
  • Travel & lodging$3,16013%
  • Food & beverage$8,78535%
  • Education$1,8377%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sobi, Inc22$8,532
Lilly USA, LLC2$2,782
Pharmacyclics LLC, An Abbvie Company12$1,910
Seagen Inc.18$1,576
Pfizer18$782
Incyte Corporation11$781
Janssen Scientific Affairs, LLC1$780
Bristol Myers Squibb16$504
Johnson & Johnson20$446
AstraZeneca16$416
AVEO Pharmaceuticals, Inc.6$399
Sanofi10$392
E.r. Squibb & Sons, L.L.C.7$379
Astellas Pharma US Inc7$313
AbbVie11$282
Gilead9$267
Amgen5$267
Karyopharm Therapeutics Inc.4$242
Merck8$217
Takeda Pharmaceuticals U.S.A., Inc.3$202
Sanofi-aventis U.S. LLC2$200
Novartis8$183
Daiichi Sankyo Inc.7$167
Tactile Systems Technology Inc2$161
Kyowa Kirin, Inc.3$155
Stemline Therapeutics Inc.2$151
Cvrx, Inc.1$145
Genmab U.S., Inc.2$137
Mirati Therapeutics, Inc.2$133
Boston Scientific1$125
Eisai Inc.6$123
EMD Serono, Inc.2$118
GSK2$111
Servier Pharmaceuticals LLC5$107
CTI Biopharma Corp.1$106
Apellis Pharmaceuticals, Inc.1$104
ADC Therapeutics America, Inc.1$103
Array Biopharma Inc7$100
Aadi Bioscience, Inc.1$99
Springworks Therapeutics, Inc.4$90
Bayer4$84
Regeneron Healthcare Solutions, Inc.3$79
Menarini Silicon Biosystems, Inc.1$78
Coherus Oncology, Inc.3$70
Ipsen Biopharmaceuticals, Inc3$47
Jazz Pharmaceuticals Inc.2$45
Sun Pharmaceutical Industries Inc.2$39
Caris MPI, Inc.1$28
Dova Pharmaceuticals1$25
Genentech USA, Inc.1$25
Astellas Pharma Global Development1$24
Progenics Pharmaceuticals, Inc.1$24
Alnylam Pharmaceuticals Inc.1$23
Boehringer Ingelheim1$23
Tempus AI, Inc1$22
Puma Biotechnology, Inc.1$21
Adaptive Biotechnologies Corporation1$21
Taiho Oncology, Inc.1$20
Myovant Sciences Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,795 in reported general payments places this provider in the 95th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona →

Medicare billing

Part B allowed, 2024
$7,028
Medicare patients
25
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Phoenix

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →